Antibiotic exposure and IBD development among children: a population-based cohort study

Area of Science:

• Gastroenterology
• Pediatric Health
• Microbiome Research

Background:

• Antibiotic use in children is common, but its long-term effects on gut health are not fully understood.
• Emerging evidence suggests a link between early-life antibiotic exposure and immune-mediated diseases.
• Inflammatory bowel disease (IBD) has a complex etiology, potentially influenced by environmental factors like antibiotic use.

Purpose of the Study:

• To investigate the association between childhood exposure to antianaerobic antibiotics and the subsequent development of inflammatory bowel disease (IBD).
• To explore the impact of age at exposure and cumulative antibiotic exposure on IBD risk.

Main Methods:

• Retrospective cohort study using data from 464 UK general practices (1994-2009).
• Included children with at least 2 years of follow-up, excluding those with prior IBD.
• Defined antianaerobic antibiotics and analyzed prescription data to assess exposure and IBD development.

Main Results:

• Over 1 million children contributed 6.6 million person-years of follow-up; 748 developed IBD.
• Incidence of IBD was higher in children exposed to antianaerobic antibiotics (1.52/10000 person-years) compared to unexposed (0.83/10000 person-years).
• Exposure before age 1 had a significantly higher adjusted hazard ratio (5.51) for IBD, with a dose-response relationship observed for cumulative exposure.

Conclusions:

• Childhood exposure to antianaerobic antibiotics is associated with an increased risk of developing IBD.
• The timing and cumulative dose of antianaerobic antibiotic exposure appear to influence IBD development.
• These findings highlight the potential long-term consequences of early-life antibiotic use on gut health and immune development.